New Delhi [India], January 26 (ANI): The Department of Biotechnology highlighted the Atma Nirbhar Bharat Abhiyan and showcased the COVID-19 vaccine development process in their tableau at Rajpath on Tuesday.
New York [US], January 26 (ANI): US biotechnology firm Moderna announced on Monday that its COVID-19 vaccine has demonstrated a 'neutralising impact' on coronavirus variants first found in the United Kingdom and South Africa.
New Delhi [India], January 22 (ANI): In a remarkable finding, India's indigenous Covid-19 vaccine--COVAXIN developed by the Bharat Biotech and Indian Council of Medical Research (ICMR) has shown high safety and immunogenicity during the phase 1 clinical trial, according to the findings of th
Chennai (Tamil Nadu) [India], January 22 (ANI): Tamil Nadu Health Minister Dr C Vijayabaskar received Bharat Biotech's Covaxin shot in Chennai on Friday.
Bengaluru (Karnataka) [India], January 19 (ANI): After the Karnataka Association of Resident Doctors' objected to taking the Covaxin shot developed by Hyderabad-based Bharat Biotech and requested the government to use Covishield vaccine instead, Karnataka Health Minister Dr K Sudhakar on Tue
Chennai (Tamil Nadu) [India], January 18 (ANI): Tamil Nadu Health Secretary Dr J Radhakrishnan was inoculated against COVID-19 on the second day of the vaccination drive in Trichy on Sunday.
New Delhi [India] January 16 (ANI): As India started its vaccination drive against COVID-19 on Saturday, members of Resident Doctors' Association (RDA) at RML hospital here expressed doubts over Covaxin, saying there is "lack of complete trial".
New Delhi [India], January 16 (ANI): Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe
New Delhi [India], January 15 (ANI): As India awaits the vaccine roll-out anxiously, the Delhi government on Friday announced that the Serum Institute of India (SII)-manufactured Covishield vaccine will be administered at 75 Delhi government and private hospitals while Bharat Biotech's CO
New Delhi [India], January 14 (ANI): Congress leader Manish Tewari on Wednesday said that emergency use authorization to COVID-19 vaccine 'Covaxin' raises concerns on its efficacy as phase three trials have not been completed and its roll out can't be used as phase three trial. He said India
Mumbai (Mharashtra) [India], January 13 (ANI): Maharashtra has received a total of 9,83,000 COVID-19 vaccine doses, of which 9,63,000 have come from Serum Institute of India and the remaining from Bharat Biotech, said Rajesh Tope, state's Health Minister.
Hyderabad (Telangana) [India], January 13 (ANI): The Bharat Biotech International Limited (BBIL) has announced the successful air-shipment of its COVID-19 vaccine 'Covaxin' to 11 cities in the country in the early hours of Wednesday.